| 000 | 01478 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512005011.0 | ||
| 264 | 0 | _c19890804 | |
| 008 | 198908s 0 0 eng d | ||
| 022 | _a0009-7330 | ||
| 024 | 7 |
_a10.1161/01.res.65.1.154 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKauffman, R F | |
| 245 | 0 | 0 |
_aCharacterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranes. _h[electronic resource] |
| 260 |
_bCirculation research _cJul 1989 |
||
| 300 |
_a154-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aCardiotonic Agents _xmetabolism |
| 650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aIndoles _xmetabolism |
| 650 | 0 | 4 | _aIons |
| 650 | 0 | 4 |
_aMembranes _xmetabolism |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 | _aOxindoles |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xmetabolism |
| 650 | 0 | 4 |
_aPyridazines _xmetabolism |
| 650 | 0 | 4 |
_aSarcoplasmic Reticulum _xmetabolism |
| 700 | 1 | _aUtterback, B G | |
| 700 | 1 | _aRobertson, D W | |
| 773 | 0 |
_tCirculation research _gvol. 65 _gno. 1 _gp. 154-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.res.65.1.154 _zAvailable from publisher's website |
| 999 |
_c2550277 _d2550277 |
||